The Longitude Prize on ALS
June 2025 – February 2031
£7.5 million prize pot
The Longitude Prize on ALS is a £7m international programme that seeks to incentivise the use of AI-based approaches to transform therapeutic discovery for the treatment of amyotrophic lateral sclerosis (ALS), the most common form of motor neurone disease (MND). The Prize launches on 25th June 2025, when it will open for applications.
The Longitude Prize on Dementia
September 2022 – September 2026
£4.42 million prize pot
The Longitude Prize on Dementia will be awarded to the creator of a breakthrough technology that learns from a person living with dementia, adapting and compensating for their condition as it progresses, and enabling them to continue living independently for longer. We announced the five finalist teams in October 2024, via BBC One’s The One Show.
The Longitude Prize on AMR
May 2014 – September 2022
£8 million prize pot
We are proud to announce that the £8 million Longitude Prize on Antimicrobial Resistance (AMR) has been awarded to Sysmex Astrego for the PA-100 AST System. The game-changing solution is a novel point-of-care diagnostic test that rapidly and accurately identifies the presence of a bacterial infection and the right antibiotic to prescribe.
